115 related articles for article (PubMed ID: 17487361)
1. Potential mechanisms for the synergistic cytotoxicity elicited by 4-hydroxytamoxifen and epigallocatechin gallate in MDA-MB-231 cells.
Stuart EC; Larsen L; Rosengren RJ
Int J Oncol; 2007 Jun; 30(6):1407-12. PubMed ID: 17487361
[TBL] [Abstract][Full Text] [Related]
2. The combination of raloxifene and epigallocatechin gallate suppresses growth and induces apoptosis in MDA-MB-231 cells.
Stuart EC; Rosengren RJ
Life Sci; 2008 Apr; 82(17-18):943-8. PubMed ID: 18371987
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells.
Chisholm K; Bray BJ; Rosengren RJ
Anticancer Drugs; 2004 Oct; 15(9):889-97. PubMed ID: 15457130
[TBL] [Abstract][Full Text] [Related]
4. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
5. Increased radiation sensitivity of an eosinophilic cell line following treatment with epigallocatechin-gallate, resveratrol and curcuma.
Baatout S; Derradji H; Jacquet P; Mergeay M
Int J Mol Med; 2005 Feb; 15(2):337-52. PubMed ID: 15647852
[TBL] [Abstract][Full Text] [Related]
6. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78.
Ermakova SP; Kang BS; Choi BY; Choi HS; Schuster TF; Ma WY; Bode AM; Dong Z
Cancer Res; 2006 Sep; 66(18):9260-9. PubMed ID: 16982771
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative and apoptotic effect of epigallocatechin-3-gallate on Ishikawa cells is accompanied by sex steroid receptor downregulation.
Park SB; Bae JW; Kim JM; Lee SG; Han M
Int J Mol Med; 2012 Nov; 30(5):1211-8. PubMed ID: 22923012
[TBL] [Abstract][Full Text] [Related]
9. The combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivo.
Somers-Edgar TJ; Scandlyn MJ; Stuart EC; Le Nedelec MJ; Valentine SP; Rosengren RJ
Int J Cancer; 2008 May; 122(9):1966-71. PubMed ID: 18098290
[TBL] [Abstract][Full Text] [Related]
10. [Epigallocatechin-3-gallate induces G1 phase cell cycle arrest in KB cells].
Jiang S; Chen XL; Ding Y; Chen ZW; Zhu LJ; Feng H; Zhen MC; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1381-3. PubMed ID: 19620059
[TBL] [Abstract][Full Text] [Related]
11. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
12. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
Huh SW; Bae SM; Kim YW; Lee JM; Namkoong SE; Lee IP; Kim SH; Kim CK; Ahn WS
Gynecol Oncol; 2004 Sep; 94(3):760-8. PubMed ID: 15350370
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin gallate dose-dependently induces apoptosis or necrosis in human MCF-7 cells.
Hsuuw YD; Chan WH
Ann N Y Acad Sci; 2007 Jan; 1095():428-40. PubMed ID: 17404055
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effects of the major tea polyphenol, (-)-epigallocatechin gallate and retinoic acid in cervical adenocarcinoma.
Yokoyama M; Noguchi M; Nakao Y; Ysunaga M; Yamasaki F; Iwasaka T
Gynecol Oncol; 2008 Feb; 108(2):326-31. PubMed ID: 18035403
[TBL] [Abstract][Full Text] [Related]
15. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells.
Hsieh TC; Wu JM
Int J Oncol; 2008 Oct; 33(4):851-9. PubMed ID: 18813800
[TBL] [Abstract][Full Text] [Related]
16. [Effects of different catechins on cell cycle arrest and induction of apoptosis in LoVo cells].
Tan X; Zhou D; Zhang Y; Jiang B
Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Nov; 34(6):333-5. PubMed ID: 11860942
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
Liang YC; Lin-Shiau SY; Chen CF; Lin JK
J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel/epigallocatechin gallate coloaded liposome: a synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells.
Ramadass SK; Anantharaman NV; Subramanian S; Sivasubramanian S; Madhan B
Colloids Surf B Biointerfaces; 2015 Jan; 125():65-72. PubMed ID: 25437065
[TBL] [Abstract][Full Text] [Related]
20. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK
Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
